ENFN
Enfusion, Inc. (ENFN)
Last Price$11.10.1%
Market Cap$1,440.8M
LTM Free Cash Flow
$23.8M
Reverse DCF (Implied FCF growth)
15.9%
3Y Free Cash Flow CAGR
N/A
LTM Revenue
$201.6M
Reverse DCF (Implied Revenue growth)
17.8%
at normalized FCF margin 10.2%
3Y Revenue CAGR
21.8%

ENFN Reverse DCF Model

Implied FCF growth
Implied Revenue growth

Reverse DCF Assumptions and Outputs

as of Dec 31, 2024
Long-Term growth rate
4.0%
FX rate
1.0
Last share price
10.3
Implied FCF growth 1-10Y
15.9%

Implied Free Cash Flow growth vs Historical average vs Industry growth

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

ENFN Free Cash Flow

Annual
Quarterly
LTM
(10.0M)0.010.0M20.0M30.0MDec'19Dec'20Dec'21Dec'22Dec'23Dec'24

ENFN Growth

Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Crunching data... Almost there!
Crunching data... Almost there!

ENFN vs Peer Set: Reverse DCF comparison

Explore more intrinsic value tools hub for ENFN

FAQ

What is Enfusion, Inc. Reverse DCF (discounted cash flow) valuation?

As of Dec 31, 2024, Enfusion, Inc.'s Reverse Discounted Cash Flow (DCF) valuation estimates its Free Cash Flow growth at 15.9%.

What is Enfusion, Inc. WACC?

As of Dec 31, 2024, Enfusion, Inc.'s Weighted Average Cost of Capital (WACC) is approximately 8.8%.

What is Enfusion, Inc. Free Cash Flow?

As of Dec 31, 2024, Enfusion, Inc.'s Free Cash Flow is $23.8M.